Stock detail
Moonlake Immunotherapeutics (MLTX) stock price, chart, and key data
View Moonlake Immunotherapeutics stock price, chart movement, and headline metrics on Woodstock's stock detail page.
Stock detail
Moonlake Immunotherapeutics
MLTX · XNAS
$10.68
-1.38%
-$0.15
Pre-market $10.64 (-0.37%)
Key metrics
52-week range
$0.25 - $7.00
Close price
$10.83
Market cap
$920.9M
P/E ratio
-2.85
Beta
2.29
About the company
Moonlake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients. It is currently developing SLK in inflammatory diseases in dermatology and rheumatology where the pathophysiology is known to be driven by IL-17A and IL-17F.
Analyst rating summary
A current read on analyst sentiment from the insight feed.
Mean target
$33.00
8
Buy
/ 9
Recent calls
10/05/2026
Wedbush
Yun Zhong
Buy · Price target $34.00
10/05/2026
H.C. Wainwright
Ram Selvaraju
Buy · Price target $50.00
10/01/2026
TD Cowen
Phil Nadeau
Buy
24/5 Trading
Act on the stock when the timing works for you.
With Woodstock, you can move from chart review to order placement in one flow. Trade eligible US stocks 24/5, even outside regular market hours.
*24-hour trading is available except during system maintenance. Some stocks are not eligible for extended-hours trading.
Download the app